Nighttime Sleep and Daytime Sleepiness Improved With Pimavanserin During Treatment of Parkinson’s Disease Psychosis

Conclusion The data from the trials suggest that nighttime sleep improved with administration of pimavanserin, a novel 5-HT2A receptor inverse agonist/antagonist.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Review Articles Source Type: research